INDSWFTLAB

Ind-Swift Laboratories Share Price

₹103.00 -1.01 (-0.97%)

21 Nov, 2024 14:16

SIP TrendupStart SIP in INDSWFTLAB

Start SIP

Performance

  • Low
  • ₹102
  • High
  • ₹104
  • 52 Week Low
  • ₹90
  • 52 Week High
  • ₹186
  • Open Price₹0
  • Previous Close₹104
  • Volume11,694

Investment Returns

  • Over 1 Month -21.82%
  • Over 3 Month -24.61%
  • Over 6 Month -6.58%
  • Over 1 Year + 9.87%
SIP Lightning

Smart Investing Starts Here Start SIP with Ind-Swift Laboratories for Steady Growth!

Invest Now

Ind-Swift Laboratories Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 2.3
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 609
  • P/B Ratio
  • 0.7
  • Average True Range
  • 2.85
  • EPS
  • 17.29
  • Dividend Yield
  • 0
  • MACD Signal
  • -4.38
  • RSI
  • 27.9
  • MFI
  • 9.5

Ind-Swift Laboratories Financials

Ind-Swift Laboratories Technicals

EMA & SMA

Current Price
₹103.00
-1.01 (-0.97%)
pointer
  • stock-down_img
  • Bullish Moving Average 0
  • stock-up_img
  • Bearish Moving Average 16
  • 20 Day
  • ₹112.93
  • 50 Day
  • ₹121.18
  • 100 Day
  • ₹125.02
  • 200 Day
  • ₹120.73

Resistance and Support

104.33 Pivot Speed
  • R3 105.67
  • R2 105.33
  • R1 104.67
  • S1 103.67
  • S2 103.33
  • S3 102.67

What's your outlook on Ind-Swift Laboratories?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ind-Swift Labs. (Nse) has an operating revenue of Rs. 725.97 Cr. on a trailing 12-month basis. An annual revenue growth of 7% is good, Pre-tax margin of 45% is great, ROE of 45% is exceptional. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is trading below to its key moving averages. It needs to take out these levels and stay above it to make any meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 7 which is a POOR score indicating inconsistency in earnings, a RS Rating of 25 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 36 indicates it belongs to a strong industry group of Medical-Generic Drugs and a Master Score of D is close to being the worst. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ind-Swift Laboratories Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-11 Quarterly Results
2024-08-12 Quarterly Results
2024-06-27 Preferential issue of shares
2024-05-13 Audited Results
2024-02-12 Quarterly Results

Ind-Swift Laboratories F&O

Ind-Swift Laboratories Shareholding Pattern

42%
0.65%
36.63%
20.72%

About Ind-Swift Laboratories

  • NSE Symbol
  • INDSWFTLAB
  • BSE Symbol
  • 532305
  • Chairman & Managing Director
  • Mr. Navrattan Munjal
  • ISIN
  • INE915B01019

Similar Stocks to Ind-Swift Laboratories

Ind-Swift Laboratories FAQs

Ind-Swift Laboratories share price is ₹103 As on 21 November, 2024 | 14:02

The Market Cap of Ind-Swift Laboratories is ₹608.6 Cr As on 21 November, 2024 | 14:02

The P/E ratio of Ind-Swift Laboratories is 2.3 As on 21 November, 2024 | 14:02

The PB ratio of Ind-Swift Laboratories is 0.7 As on 21 November, 2024 | 14:02

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23